Loading clinical trials...
Loading clinical trials...
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Conditions
Interventions
Lubiprostone
Locations
85
United States
University of South Alabama Women's and Children's Hospital
Mobile, Alabama, United States
Arizona Children's Center at Maricopa Medical Center
Phoenix, Arizona, United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Northwest Arkansas Pediatric Clinic
Fayetteville, Arkansas, United States
Arkansas Childrens Hospital Research Institute
Little Rock, Arkansas, United States
WCCT Global
Costa Mesa, California, United States
Start Date
February 26, 2014
Primary Completion Date
May 1, 2017
Completion Date
May 1, 2017
Last Updated
January 21, 2020
NCT07202481
NCT07065942
NCT04082689
NCT04666155
NCT07483229
NCT07427914
Lead Sponsor
Sucampo Pharma Americas, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions